Profiling of drug response mechanisms and patient sub-populations through readouts from a biobank of patient-derived neurons
Collaboration with NeuroKaire: Daphna Laifenfeld PhD, Tal Birnberg PhD, David Pattison, Claudia Albeldas, Elena Kagan
Introducing CLE-905, a Potent Dual M1/M4 Receptor Agonist in Development for Treatment of Schizophrenia and Additional Psychiatric Disorders
Hadile Ounallah-Saad, PhD
A Phase 2 Randomized Controlled Adjunctive Treatment Trial with CLE-100 Esketamine Tablet for Patients with Major Depressive Disorder and Inadequate Response to Antidepressants, During the COVID-19 Pandemic
Maurizio Fava, Oren Berkowitz, Sanjay J. Mathew, Michael E. Thase, Andrew A. Nierenberg, Dan V. Iosifescu, L. Alison McInnes, Cristina Cusin, Robert Berman, Eli Eyal, Ari Gershon, Esther Lukasiewicz-Hagai